Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 2

3(33.3%)

Phase 3

1(11.1%)

9Total

N/A(5)

Phase 2(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07184398Not ApplicableCompleted

Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment

Role: collaborator

NCT03448055Not ApplicableUnknown

Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health

Role: lead

NCT00935610Phase 2Completed

Effect of Immunocal® With Exercise Versus Casein With Exercise on Aging Processes in Elderly Persons

Role: lead

NCT02938104Not ApplicableCompleted

Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery

Role: collaborator

NCT01366859Phase 2Completed

Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior

Role: collaborator

NCT01356264Phase 2Completed

Multimodal Prehabilitation for Colorectal Surgery

Role: collaborator

NCT01046383Phase 3Terminated

Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients

Role: lead

NCT01727570Not ApplicableCompleted

Prehabilitation to Overcome the Stress of Surgery: the Role of Nutrition in Enhancing Postoperative Functional Capacity

Role: collaborator

NCT01424904Not ApplicableCompleted

DGB-01 Effects on Endurance Exercise

Role: collaborator

All 9 trials loaded